Codiak BioSciences Inc.

3.77-0.3700-8.94%Vol 64.63K1Y Perf -78.67%
Jun 28th, 2022 16:00 DELAYED
BID3.25 ASK4.12
Open4.14 Previous Close4.14
Pre-Market- After-Market3.77
 - -  - -%
Target Price
12.50 
Analyst Rating
Strong Buy 1.00
Potential %
231.57 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     46.26
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
7.52 
Earnings Rating
Market Cap84.80M 
Earnings Date
4th Aug 2022
Alpha-0.06 Standard Deviation0.44
Beta4.89 

Today's Price Range

3.694.25

52W Range

2.2122.95

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
41.78%
1 Month
61.09%
3 Months
-25.67%
6 Months
-60.46%
1 Year
-78.67%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CDAK3.77-0.3700-8.94
AAPL137.44-4.2200-2.98
GOOG2 251.43-81.0200-3.47
MSFT256.48-8.4100-3.17
XOM91.502.47002.77
WFC40.18-0.0600-0.15
JNJ176.94-5.1800-2.84
FB196.640.99000.51
GE65.88-0.8300-1.24
JPM115.82-0.5600-0.48
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.80-0.3655.00
Q04 2021-1.03-0.7527.18
Q03 2021-0.95-0.97-2.11
Q02 2021-1.00-0.991.00
Q01 2021-1.01-0.5149.51
Q04 2020-1.11-1.14-2.70
Q03 2020-3.94-12.83-225.63
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date4th Aug 2022
Estimated EPS Next Report-0.78
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume64.63K
Shares Outstanding22.49K
Shares Float12.63M
Trades Count1.13K
Dollar Volume252.12K
Avg. Volume298.21K
Avg. Weekly Volume493.37K
Avg. Monthly Volume240.71K
Avg. Quarterly Volume160.54K

Codiak BioSciences Inc. (NASDAQ: CDAK) stock closed at 4.14 per share at the end of the most recent trading day (a 6.43% change compared to the prior day closing price) with a volume of 150.19K shares and market capitalization of 84.80M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 101 people. Codiak BioSciences Inc. CEO is Douglas E. Williams.

The one-year performance of Codiak BioSciences Inc. stock is -78.67%, while year-to-date (YTD) performance is -62.84%. CDAK stock has a five-year performance of %. Its 52-week range is between 2.21 and 22.95, which gives CDAK stock a 52-week price range ratio of 7.52%

Codiak BioSciences Inc. currently has a PE ratio of -2.50, a price-to-book (PB) ratio of 1.81, a price-to-sale (PS) ratio of 4.15, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -21.08%, a ROC of -26.61% and a ROE of -61.58%. The company’s profit margin is -%, its EBITDA margin is -116.20%, and its revenue ttm is $22.45 Million , which makes it $1.00 revenue per share.

Of the last four earnings reports from Codiak BioSciences Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.78 for the next earnings report. Codiak BioSciences Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Codiak BioSciences Inc. is Strong Buy (1), with a target price of $12.5, which is +231.57% compared to the current price. The earnings rating for Codiak BioSciences Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Codiak BioSciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Codiak BioSciences Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 17.80, ATR14 : 0.45, CCI20 : 218.71, Chaikin Money Flow : 0.29, MACD : 0.15, Money Flow Index : 87.85, ROC : 26.99, RSI : 65.94, STOCH (14,3) : 95.07, STOCH RSI : 1.00, UO : 64.19, Williams %R : -4.93), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Codiak BioSciences Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Codiak BioSciences Inc.

Codiak BioSciences Inc is a development-stage biopharmaceutical company focused on the development of exosome-based therapeutics aimed at treating a broad range of diseases, including oncology, neuro-oncology, neurology, neuromuscular disease, infectious disease and rare disease.

CEO: Douglas E. Williams

Telephone: +1 617 949-4100

Address: 35 CambridgePark Drive, Cambridge 02140, MA, US

Number of employees: 101

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

55%45%

Bearish Bullish

60%40%

News

Stocktwits